A recombinant Artemisia vulgaris pollen adjuvanted Art v 1 protein-based vaccine treats allergic rhinitis and bronchial asthma using pre- and co-seasonal ultrashort immunotherapy regimens in sensitized mice

Allergic rhinitis is an important risk factor for bronchial asthma. Allergen-specific immunotherapy (ASIT) is the gold standard for treatment of allergic rhinitis, conjunctivitis, and asthma. A disadvantage of current ASIT methods is the length of therapy which requires numerous allergen administrat...

Descripción completa

Detalles Bibliográficos
Autores principales: Babayeva, Meruert, Tabynov, Kairat, Nurpeisov, Tair, Fomin, Gleb, Renukaradhya, Gourapura J., Petrovsky, Nikolai, Tabynov, Kaissar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682083/
https://www.ncbi.nlm.nih.gov/pubmed/36439113
http://dx.doi.org/10.3389/fimmu.2022.983621

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682083/
https://www.ncbi.nlm.nih.gov/pubmed/36439113
http://dx.doi.org/10.3389/fimmu.2022.983621

Ejemplares similares